Fuganding® -cosunter

Fuganding® 【Tenofovir Disoproxil Fumarate Capsules】

Tenofovir disoproxil fumarate is an inhibitor of nucleotide reverse transcriptase for the treatment of chronic hepatitis B. A number of studies at home and abroad show that tenofovir disoproxil fumarate has strong anti HBV effect and low drug resistance, which is effective for chronic hepatitis B patients who have experienced unsuccessful treatment with a variety of nucleotides. As the most advanced, optimal, effective and safest anti HBV drug at present, tenofovir disoproxil fumarate is recommended as a first-line drug by many guidelines at home and abroad such as guideline of American Association for the Study of Liver Diseases and guideline of European Association for the Study of the Liver, etc.

Generic name：	Tenofovir Disoproxil Fumarate Capsules	Commodity name：	Fuganding®
English name：	Tenofovir Disoproxil Fumarate Capsules	Chinese name：	Fuganding
character：	The content is white or off-white powder.	Specifications：	300 mg
component：
indication：	Chronic hepatitis B (see the instructions for the details).
usage and dosage：	Recommended dose for adults and children aged 12 and over 12 years (35 kg or above) to treat chronic hepatitis B: the dose is 300 mg (one capsule) each time, qd, po, taken on an empty stomach or with food. (See instructions for details)
Adverse reactions：
taboo：
matters needing attention：
Medication for pregnant women：
Medication for the elderly：
Medication for children：
Drug action：
Drug overdose：
Drug toxicology：
Approval number：	CFDA Approval Number H20170005